etidronate has been researched along with Injuries, Spinal Cord in 22 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "He developed bladder stones and electrohydraulic lithotripsy (EHL) was performed in May 2002." | 5.33 | Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosph ( Buczynski, AZ; Fraser, WD; Grases, F; Heilberg, IP; Hughes, PL; Jonsson, O; Kohri, K; Schurch, B; Sett, P; Singh, G; Soni, BM; Tozawa, K; Vaidyanathan, S; Watson, ID; Wyndaele, JJ; Yasui, T, 2005) |
| "It is attributed to an increase in bone resorption and diminished bone formation characterized clinically by elevated serum calcium levels, hypercalciuria, increased risk of urinary lithiasis, and renal failure." | 5.29 | Successful treatment of immobilization hypercalcemia using calcitonin and etidronate. ( Cross, LL; Meythaler, JM; Tuel, SM, 1993) |
| "The goal of the present study was to use intravenous etidronate in the acute phase of heterotopic ossification (HO) in an attempt to achieve a high initial drug concentration at the site of the active ectopic ossification." | 3.68 | Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification. ( Banovac, K; Bowker, JJ; Gonzalez, F; Wade, N, 1993) |
| "After discontinuation of drug therapy, recurrence was variable but less than expected." | 2.64 | Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. ( Miller, JM; Niemann, KM; Stover, SL, 1976) |
| "After patients with osteoporosis are identified, the challenge is to treat them appropriately." | 2.47 | Treatments for osteoporosis in people with a disability. ( Smith, EM, 2011) |
| "Neurogenic heterotopic ossification (NHO) is a frequent complication in spinal cord injury (SCI) that is often difficult to treat." | 2.41 | Neurogenic heterotopic ossification in spinal cord injury. ( Geurts, AC; van Kuijk, AA; van Kuppevelt, HJ, 2002) |
| "He developed bladder stones and electrohydraulic lithotripsy (EHL) was performed in May 2002." | 1.33 | Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosph ( Buczynski, AZ; Fraser, WD; Grases, F; Heilberg, IP; Hughes, PL; Jonsson, O; Kohri, K; Schurch, B; Sett, P; Singh, G; Soni, BM; Tozawa, K; Vaidyanathan, S; Watson, ID; Wyndaele, JJ; Yasui, T, 2005) |
| "Formation of heterotopic ossification (HO) in soft tissue after spinal cord injury (SCI) is associated with various degrees of inflammation." | 1.32 | C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury. ( Banovac, K; Estrores, IM; Harrington, A, 2004) |
| "A case of extensive heterotopic ossification involving the left hip in a 16 year old girl who sustained non traumatic spinal paralysis at T4 ASIA scale A." | 1.31 | Management of immature heterotopic ossification (HO) of the hip. ( Banaovac, K; Bergman, SB; El Masry, WS; Jamil, F; Subbarao, JV, 2002) |
| "Etidronate was started intravenously (300 mg/day) for three days followed by oral therapy for six months (20 mg/kg/day)." | 1.30 | Treatment of heterotopic ossification after spinal cord injury. ( Banovac, K; Gonzalez, F; Renfree, KJ, 1997) |
| "Whereas the articular complications of heterotopic ossification have been well documented, the vascular complications are less well known." | 1.29 | [Heterotopic ossification and vascular compression]. ( Brissot, R; Gallien, P; Le Bot, MP; Nicolas, B; Rivier, I; Robineau, S; Sarkis, S, 1994) |
| "It is attributed to an increase in bone resorption and diminished bone formation characterized clinically by elevated serum calcium levels, hypercalciuria, increased risk of urinary lithiasis, and renal failure." | 1.29 | Successful treatment of immobilization hypercalcemia using calcitonin and etidronate. ( Cross, LL; Meythaler, JM; Tuel, SM, 1993) |
| " Diphosphonate therapy at a dosage of 10 mg/kg/day when prescribed an average of 26 days after diagnosis did not prevent radiographically evident progression of heterotopic ossification." | 1.27 | Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. ( Alday, B; Garland, DE; Venos, KG; Vogt, JC, 1983) |
| "Other causes of hair loss were ruled out." | 1.27 | Telogen effluvium: hair loss after spinal cord injury. ( Dahlin, PA; George, J; Nérette, JC, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, EM | 1 |
| Jamil, F | 1 |
| Subbarao, JV | 2 |
| Banaovac, K | 1 |
| El Masry, WS | 1 |
| Bergman, SB | 1 |
| Banovac, K | 6 |
| Sherman, AL | 1 |
| Estores, IM | 1 |
| Banovac, F | 1 |
| Estrores, IM | 1 |
| Harrington, A | 1 |
| Vaidyanathan, S | 1 |
| Watson, ID | 1 |
| Jonsson, O | 1 |
| Buczynski, AZ | 1 |
| Grases, F | 1 |
| Heilberg, IP | 1 |
| Yasui, T | 1 |
| Wyndaele, JJ | 1 |
| Tozawa, K | 1 |
| Kohri, K | 1 |
| Schurch, B | 1 |
| Hughes, PL | 1 |
| Singh, G | 1 |
| Soni, BM | 1 |
| Sett, P | 1 |
| Fraser, WD | 1 |
| Freed, JH | 1 |
| Hahn, H | 1 |
| Menter, R | 1 |
| Dillon, T | 1 |
| Garland, DE | 1 |
| Alday, B | 1 |
| Venos, KG | 1 |
| Vogt, JC | 1 |
| Merli, GJ | 1 |
| McElwain, GE | 1 |
| Adler, AG | 1 |
| Martin, JH | 1 |
| Roberts, JD | 1 |
| Schnall, B | 1 |
| Ditunno, JF | 1 |
| Dahlin, PA | 1 |
| George, J | 1 |
| Nérette, JC | 1 |
| Finerman, GA | 1 |
| Stover, SL | 2 |
| Gallien, P | 1 |
| Nicolas, B | 1 |
| Le Bot, MP | 1 |
| Robineau, S | 1 |
| Rivier, I | 1 |
| Sarkis, S | 1 |
| Brissot, R | 1 |
| Gonzalez, F | 3 |
| Wade, N | 1 |
| Bowker, JJ | 1 |
| Biering-Sørensen, F | 1 |
| Tøndevold, E | 1 |
| Meythaler, JM | 1 |
| Tuel, SM | 1 |
| Cross, LL | 1 |
| Pearson, EG | 1 |
| Nance, PW | 1 |
| Leslie, WD | 1 |
| Ludwig, S | 1 |
| Renfree, KJ | 1 |
| Blankenship, LD | 1 |
| Strommen, JA | 1 |
| van Kuijk, AA | 1 |
| Geurts, AC | 1 |
| van Kuppevelt, HJ | 1 |
| Niemann, KM | 1 |
| Miller, JM | 1 |
3 reviews available for etidronate and Injuries, Spinal Cord
| Article | Year |
|---|---|
Treatments for osteoporosis in people with a disability.
Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Disabled Persons; Etidronic Acid; Hu | 2011 |
Prevention and treatment of heterotopic ossification after spinal cord injury.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Etidronic Acid; Humans; Ossifica | 2004 |
Neurogenic heterotopic ossification in spinal cord injury.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcitonin; Diagnosis, Differential; Etidronic Acid; Glucoc | 2002 |
3 trials available for etidronate and Injuries, Spinal Cord
| Article | Year |
|---|---|
Evaluation and management of heterotopic ossification in patients with spinal cord injury.
Topics: Adolescent; Adult; Etidronic Acid; Female; Humans; Male; Middle Aged; Ossification, Heterotopic; Rad | 1997 |
Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury.
Topics: Acute Disease; Adult; Bone Density; Bone Resorption; Drug Administration Schedule; Etidronic Acid; F | 1997 |
Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients.
Topics: Adult; Etidronic Acid; Humans; Myositis Ossificans; Organophosphorus Compounds; Postoperative Care; | 1976 |
16 other studies available for etidronate and Injuries, Spinal Cord
| Article | Year |
|---|---|
Management of immature heterotopic ossification (HO) of the hip.
Topics: Adolescent; Etidronic Acid; Female; Hip; Humans; Ossification, Heterotopic; Paraplegia; Radiography; | 2002 |
C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Etidronic A | 2004 |
Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosph
Topics: Adult; Bone Resorption; Calcium; Etidronic Acid; Follow-Up Studies; Humans; International Cooperatio | 2005 |
The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy.
Topics: Diphosphonates; Etidronic Acid; Hip Joint; Humans; Ossification, Heterotopic; Radionuclide Imaging; | 1982 |
Diphosphonate treatment for heterotopic ossification in spinal cord injury patients.
Topics: Adolescent; Adult; Etidronic Acid; Female; Hip Joint; Humans; Male; Ossification, Heterotopic; Radio | 1983 |
Immobilization hypercalcemia in acute spinal cord injury treated with etidronate.
Topics: Acute Disease; Adult; Etidronic Acid; Humans; Hypercalcemia; Immobilization; Male; Spinal Cord Injur | 1984 |
Telogen effluvium: hair loss after spinal cord injury.
Topics: Adult; Alopecia; Etidronic Acid; Humans; Hysteria; Male; Ossification, Heterotopic; Spinal Cord Inju | 1984 |
Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP.
Topics: Double-Blind Method; Etidronic Acid; Hip Prosthesis; Humans; Ossification, Heterotopic; Placebos; Ra | 1981 |
[Heterotopic ossification and vascular compression].
Topics: Adult; Craniocerebral Trauma; Etidronic Acid; Femoral Vein; Humans; Indomethacin; Male; Middle Aged; | 1994 |
Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
Topics: Administration, Oral; Adolescent; Adult; Drug Administration Schedule; Edema; Etidronic Acid; Female | 1993 |
Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports.
Topics: Adolescent; Adult; Etidronic Acid; Hip; Humans; Indomethacin; Male; Ossification, Heterotopic; Recur | 1993 |
Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
Topics: Adolescent; Adult; Bone Resorption; Calcitonin; Drug Therapy, Combination; Etidronic Acid; Female; H | 1993 |
Treatment of heterotopic ossification after spinal cord injury.
Topics: Administration, Oral; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Sched | 1997 |
The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
Topics: Administration, Oral; Adolescent; Adult; Etidronic Acid; Female; Follow-Up Studies; Humans; Infusion | 2000 |
27-year-old man with a swollen leg.
Topics: Adult; Cervical Vertebrae; Diagnosis, Differential; Edema; Etidronic Acid; Exercise Therapy; Humans; | 2000 |
Pseudoarthrosis in heterotopic ossification in spinal cord-injured patients.
Topics: Aged; Ankylosis; Craniocerebral Trauma; Etidronic Acid; Humans; Male; Middle Aged; Ossification, Het | 1990 |